Murali Prahalad
Director/Board Member at MARAVAI LIFESCIENCES HOLDINGS, INC.
Net worth: 388 615 $ as of 31/03/2024
Profile
Murali K.
Prahalad is currently the President & Chief Executive Officer at Iridia, Inc. and the Director at Epic Sciences, Inc. He is also a Director at Maravai Life Sciences, Inc. and Maravai Lifesciences Holdings, Inc. Previously, he held the position of Vice President-Business Development at Sequenom, Inc. and Vice President-Corporate Strategy at Life Technologies Corp.
from 2012 to 2013.
Dr. Prahalad received his graduate and doctorate degrees from Harvard University and his undergraduate degree from the University of Michigan.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 17/07/2023 | 44,823 ( 0.03% ) | 388 615 $ | 31/03/2024 |
Murali Prahalad active positions
| Companies | Position | Start |
|---|---|---|
| MARAVAI LIFESCIENCES HOLDINGS, INC. | Director/Board Member | 01/08/2016 |
Epic Sciences, Inc.
 Epic Sciences, Inc. Medical SpecialtiesHealth Technology Epic Sciences, Inc. develops novel diagnostics to the treatment and management of cancer. It develops sensitive diagnostic tests to molecularly characterize circulating tumor cells in the blood. The firm also offers fluid-phase biopsy that identifies rare cell of interest in the blood; and provides cancer management through earlier diagnosis, staging and therapeutic selections. The company was founded by David M. Nelson in 2008 and is headquartered in San Diego, CA. | Director/Board Member | 01/04/2019 |
Iridia, Inc.
 Iridia, Inc. Miscellaneous Commercial ServicesCommercial Services Iridia, Inc. operates as a biotechnology company. It offers research and development services. The company was founded by James P. Linton in 2016 and is headquartered in Carlsbad, CA. | Chief Executive Officer | 01/11/2019 |
Maravai Life Sciences, Inc.
 Maravai Life Sciences, Inc. Financial ConglomeratesFinance Maravai Life Sciences, Inc. provides investment services. It focuses on acquiring companies and products in the diagnostics and life sciences industry. The company was founded by Carl W. Hull and Eric Tardiff in March 18, 2014 and is headquartered in San Diego, CA. | Director/Board Member | - |
Former positions of Murali Prahalad
| Companies | Position | End |
|---|---|---|
Life Technologies Corp.
 Life Technologies Corp. Miscellaneous Commercial ServicesCommercial Services Life Technologies Corp. provides products in the areas of scientific research, genetic analysis and applied sciences. Its brands include Invitrogen, Applied Biosystems, Gibco, Molecular Probes, Noves, Ambion and Ion Torrent. The firm’s portfolio includes the most cited products and technologies in qPCR, capillary electrophoresis sequencing, nextgeneration sequencing, molecular diagnostics, forensics, cell culture and analysis, and agriculture research. The company was founded on November 21, 2008 and is headquartered in Carlsbad, CA. | Corporate Officer/Principal | 01/01/2013 |
| SEQUENOM, INC. | Corporate Officer/Principal | - |
Training of Murali Prahalad
| Harvard University | Doctorate Degree |
| University of Michigan | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| MARAVAI LIFESCIENCES HOLDINGS, INC. | Health Technology |
| Private companies | 5 |
|---|---|
Sequenom, Inc.
 Sequenom, Inc. Medical SpecialtiesHealth Technology Sequenom, Inc. engages in the provision of early patient management information. It develops and commercializes molecular diagnostic testing services that serve women's health and oncology markets. The company was founded by Hubert Koester and Charles R. Cantor in October 09, 1996 and is headquartered in Burlington, NC. | Health Technology |
Life Technologies Corp.
Life Technologies Corp. Miscellaneous Commercial ServicesCommercial Services Life Technologies Corp. provides products in the areas of scientific research, genetic analysis and applied sciences. Its brands include Invitrogen, Applied Biosystems, Gibco, Molecular Probes, Noves, Ambion and Ion Torrent. The firm’s portfolio includes the most cited products and technologies in qPCR, capillary electrophoresis sequencing, nextgeneration sequencing, molecular diagnostics, forensics, cell culture and analysis, and agriculture research. The company was founded on November 21, 2008 and is headquartered in Carlsbad, CA. | Commercial Services |
Epic Sciences, Inc.
Epic Sciences, Inc. Medical SpecialtiesHealth Technology Epic Sciences, Inc. develops novel diagnostics to the treatment and management of cancer. It develops sensitive diagnostic tests to molecularly characterize circulating tumor cells in the blood. The firm also offers fluid-phase biopsy that identifies rare cell of interest in the blood; and provides cancer management through earlier diagnosis, staging and therapeutic selections. The company was founded by David M. Nelson in 2008 and is headquartered in San Diego, CA. | Health Technology |
Maravai Life Sciences, Inc.
Maravai Life Sciences, Inc. Financial ConglomeratesFinance Maravai Life Sciences, Inc. provides investment services. It focuses on acquiring companies and products in the diagnostics and life sciences industry. The company was founded by Carl W. Hull and Eric Tardiff in March 18, 2014 and is headquartered in San Diego, CA. | Finance |
Iridia, Inc.
Iridia, Inc. Miscellaneous Commercial ServicesCommercial Services Iridia, Inc. operates as a biotechnology company. It offers research and development services. The company was founded by James P. Linton in 2016 and is headquartered in Carlsbad, CA. | Commercial Services |
- Stock Market
- Insiders
- Murali Prahalad
